PrepRARE Webinar: STRIDES Study for SCA 3 – A Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia

By Dr. David Biondi

Description:

Dr. David Biondi, a Seelos Therapeutics physician, will provide an overview of the STRIDES study which is currently open to patient recruitment in the United States. The overview will include background information on the Investigational drug, SLS-005, patient eligibility criteria, study center locations, and other important study design elements.

Register HERE!

After registering, you will receive a confirmation email containing information about joining the meeting.